CSF3 and diabetes mellitus: Based on the International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus guidelines 2018, innovative treatment for insulin-dependent diabetes is as follows: glutamic acid decarboxylase (GAD)-alum vaccine, immune-modulating therapy, anti-thymocyte globulin (ATG), and granulocyte colony-stimulating factor (GCSF), and stem cell transplantation (SCT) [4].